Listing Date for Capital Increase Delayed
EDGC
245620
Signal Score
Historical Avg Return (5d)
+0.15%
Data Coverage
100%n=2535
Risk-adjusted indicator based on 2535 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Original Listing Date: June 2, 2026
- • Amended Listing Date: June 12, 2026
- • Board Resolution Date: March 20, 2026
AI Analysis Summary
Eone Diagnomics Genome Center Co., Ltd. announced an amendment to its Material Fact Report regarding a paid-in capital increase. The primary change is the delay of the new shares' listing date from June 2, 2026, to June 12, 2026, due to practical procedures with the Korea Securities Depository. This capital increase is part of a rehabilitation plan approved by the Suwon Rehabilitation Court on March 20, 2026, and includes a third-party allocation debt-to-equity swap and stock consolidation. The funds raised will be used for operating expenses after settling rehabilitation claims. The change in listing date is a minor procedural adjustment and does not alter the fundamental terms of the capital increase.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.